HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Diabetic Neuropathy, Retinopathy, and Nephropathy

Chronic hyperglycemia contributes to diabetic neuropathy, retinopathy, and nephropathy, impacting multiple organ systems and significantly reducing quality of life. Neuropathy manifests as sensory loss, pain, or autonomic dysfunction, requiring early intervention with neuroprotective agents. Retinopathy progresses from mild non-proliferative changes to vision-threatening proliferative stages, necessitating routine ophthalmic evaluations. Nephropathy, a leading cause of end-stage renal disease, is managed through glycemic control, blood pressure regulation, and renoprotective medications like SGLT2 inhibitors. Emerging therapies, including regenerative medicine and targeted molecular interventions, offer hope for slowing or reversing disease progression. Early diagnosis and multidisciplinary management remain key in preventing irreversible damage.

Committee Members
Speaker at Diabetes and Endocrinology 2025 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical Center, United States
Speaker at Diabetes and Endocrinology 2025 - F Buck Willis

F Buck Willis

IUHS School of Medicine, Saint Kitts and Nevis
Speaker at Diabetes and Endocrinology 2025 - Gretchen Holmes

Gretchen Holmes

Memorial Hospital at Gulfport, United States
Diabetes 2025 Speakers
Speaker at Diabetes and Endocrinology 2025 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes and Endocrinology 2025 - Amy Gutman

Amy Gutman

AdventHealth; Tough Love MD, United States
Speaker at Diabetes and Endocrinology 2025 - Paraskevi Theofilou

Paraskevi Theofilou

Hellenic Open University, Greece
Speaker at Diabetes and Endocrinology 2025 - Clifford Morris

Clifford Morris

Kihealth, United States
Tags

Submit your abstract Today

Watsapp